A randomized clinical trial in Ireland reports that 0.01% atropine eye drops stabilize macular choroidal thickness over two years, offering clinicians new insights into how low-dose atropine may influence...
Researchers examined the safety and efficacy of recombinant human nerve growth factor eye drops via topical application for patients with refractory epitheliopathy.
